Valeo Pharma Inc. (TSE:VPH): When Will It Breakeven?
yahoo.com
news
2022-05-31 15:32:25

With the business potentially at an important milestone, we thought we'd take a closer look at Valeo Pharma Inc.'s (TSE:VPH) future prospects. Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceutical products with primary focus on respiratory, speciality, and hospital generic products in Canada. The CA$39m market-cap company posted a loss in its most recent financial year of CA$14m and a latest trailing-twelve-month loss of CA$18m leading to an even wider gap between loss and breakeven.
